Corvus Pharmaceuticals (CRVS) Q1 2024 Earnings
CRVS·Reported May 6, 2024·After market close
Diluted EPS came in at $-0.12.
Diluted EPS
$-0.12met estimate
Consensus: $-0.12
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Corvus Pharmaceuticals's Q1 2024 earnings report.
Corvus Pharmaceuticals (CRVS) reported Q1 2024 earnings on May 6, 2024 after market close.
Corvus Pharmaceuticals reported diluted EPS of $-0.12 for Q1 2024.
EPS beat the consensus estimate of $-0.12 by $0.00.
You can read the 10-Q periodic report (0001558370-24-007093) directly on SEC EDGAR. The filing index links above go to sec.gov.